View
3
Download
0
Category
Preview:
Citation preview
Real‐World Evidence and Decision‐Making: Is It Time Yet?
Robert W. Dubois, MD, PhD
Chief Science Officer
How Big Data can revolutionize health care
NIH commits $24 million
annually for Big Data Centers of
Excellence
Efforts will harness power of complex
datasets to improve health, aid discovery,
reduce duplication
UnitedHealth Drug Evidence “Hierarchy”
Demands Observational Data be Peer‐Reviewed
“Insurer UnitedHealth Care Group Co. is willing to accept observational data to support reimbursement for prescription drugs but the information
should be published in a peer‐reviewed journal, Senior VP Clinical
Advancement Lewis Sandy.”
The Pink Sheet. March 18, 2013. UnitedHealth Drug Evidence ”Hierarchy”
Demands Observational Data be Peer‐Reviewed.
“Researchers Mine Data From Clinic, Big Insurer”
By Anna Wilde Mathews, January 15, 2013
“UnitedHealth Group and the Mayo Clinic are set to unveil a new
research initiative that will draw on millions of health‐insurance
claims and in‐depth clinical patient records…
The initiative will focus on research into "best outcomes for
patients at lower costs,"
Wall Street Journal. Researchers Mine Data from Clinic, Big Insurer. January 15, 2013.
Arthritis Research & Therapy. 2011 13:R155 doi:10.1186/ar3471
“Administrative claims data may be useful in evaluating the effectiveness of medications for RA”
ASCO Linking E‐Health Data To Promote Real‐ Time Personalized Cancer Care
The Pink Sheet. ASCO Linking E‐Health Data to Promote Real‐Time Personalized Carncer Care April 1, 2013. 8
April 1, 2013
For physicians and patients, the network will guide personalized treatment by allowing EHRs
to be queried in an effort learn what the best treatment options will be for a given patient
based on real‐world experiences and real‐time analysis of data capture in electronic records.
Types of Evidence and Perceived Usefulness in Setting Medical Policy
*Responses to questions on evidence used in making formulary and formulary management policies were similar to these responses
Joel Weisman, DIA Presentation 2013
Speakers
Robert W. Dubois, MD, PhD ‐
Chief Science Officer, National
Pharmaceutical Council
Paul Wallace, MD ‐
Senior Vice President and Director, The Lewin Group
Steve Chick– Vice President and Leader, Humana
Lucy A. Savitz, PhD, MBA‐Director of Research and Education, Intermountain Healthcare
Helen Sherman, PharmD‐Vice President, Solid Benefit Guidance
Steven D. Pearson, MD, Msc, FRCP–
President, Institute for Clinical and Economic Review
Ellen Tambor–
Research Manager, Center for Medical Technology Policy
Recommended